Literature DB >> 10965042

Activation of actin-activated MgATPase activity of myosin II by phosphorylation with MAPK-activated protein kinase-1b (RSK-2).

F Suizu1, K Ueda, T Iwasaki, M Murata-Hori, H Hosoya.   

Abstract

Regulatory light chain of myosin II (MRLC) was identified as a novel substrate of p90 ribosomal S6 kinase (RSK)-2, a Ser/Thr protein kinase which is phosphorylated and activated by mitogen-activated protein kinase (MAPK) in vitro and in vivo. Phosphopeptide map of MRLC phosphorylated by RSK-2 was identical to that by myosin light chain kinase (MLCK). Phosphoserine was recovered by the phosphoamino acid analysis of MRLC phosphorylated by RSK-2. Further, phosphorylation using recombinant glutathione S-transferase (GST) fusion proteins of HeLa MRLC2 revealed that RSK-2 phosphorylated wild-type MRLC2 (GST-wtMRLC2) but not its mutants GST-MRLC2(S19A) or GST-MRLC2(T18AS19A) (alanine substituted for Ser19 or both Ser19 and Thr18). These results revealed that RSK-2 phosphorylates MRLC at Ser19 as did MLCK. Phosphorylation of myosin II by RSK-2 resulted in activation of actin-activated MgATPase activity of myosin II. Interestingly, RSK-2 activity to phosphorylate MRLC was suppressed by phosphorylation with MAPK. RSK-2 might be a mediator that regulates myosin II activity through the MAPK cascade.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965042     DOI: 10.1093/oxfordjournals.jbchem.a022771

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  13 in total

1.  Phosphorylation of myosin II regulatory light chain is necessary for migration of HeLa cells but not for localization of myosin II at the leading edge.

Authors:  Katsumi Fumoto; Takashi Uchimura; Takahiro Iwasaki; Kozue Ueda; Hiroshi Hosoya
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Differential effects of myosin light chain kinase inhibition on contractility, force development and myosin light chain 20 phosphorylation of rat cervical and thoracic duct lymphatics.

Authors:  Zhanna V Nepiyushchikh; Sanjukta Chakraborty; Wei Wang; Michael J Davis; David C Zawieja; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2011-09-19       Impact factor: 5.182

Review 3.  Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain.

Authors:  Katusya Hirano; Dmitry N Derkach; Mayumi Hirano; Junji Nishimura; Hideo Kanaide
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

4.  Integrin-linked kinase is responsible for Ca2+-independent myosin diphosphorylation and contraction of vascular smooth muscle.

Authors:  David P Wilson; Cindy Sutherland; Meredith A Borman; Jing Ti Deng; Justin A Macdonald; Michael P Walsh
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

5.  Enhanced contractility and myosin phosphorylation induced by Ca(2+)-independent MLCK activity in hypertensive rats.

Authors:  Young-Eun Cho; Duck-Sun Ahn; Kathleen G Morgan; Young-Ho Lee
Journal:  Cardiovasc Res       Date:  2011-03-04       Impact factor: 10.787

6.  Characterization of Ca2+/calmodulin-dependent protein kinase I as a myosin II regulatory light chain kinase in vitro and in vivo.

Authors:  Futoshi Suizu; Yasuaki Fukuta; Kozue Ueda; Takahiro Iwasaki; Hiroshi Tokumitsu; Hiroshi Hosoya
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

7.  RSK2 contributes to myogenic vasoconstriction of resistance arteries by activating smooth muscle myosin and the Na+/H+ exchanger.

Authors:  Mykhaylo V Artamonov; Swapnil K Sonkusare; Miranda E Good; Ko Momotani; Masumi Eto; Brant E Isakson; Thu H Le; Eric L Cope; Zygmunt S Derewenda; Urszula Derewenda; Avril V Somlyo
Journal:  Sci Signal       Date:  2018-10-30       Impact factor: 8.192

8.  Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment.

Authors:  Muhammad Qasim; Hazir Rahman; Michael Oellerich; Abdul R Asif
Journal:  Proteome Sci       Date:  2011-09-20       Impact factor: 2.480

9.  Plasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment.

Authors:  Yvonne S Ziegler; James J Moresco; Patricia G Tu; John R Yates; Ann M Nardulli
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

10.  The p90 ribosomal S6 kinase (RSK) is a mediator of smooth muscle contractility.

Authors:  Mykhaylo Artamonov; Ko Momotani; Darkhan Utepbergenov; Aaron Franke; Alexander Khromov; Zygmunt S Derewenda; Avril V Somlyo
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.